 "cancer")
With rising cancer cases in India, the goods and services tax (GST) reduction on key cancer drugs is expected to improve patient access, say experts. The Centre has been implementing multiple measures to alleviate the financial burden of cancer treatment in India.
However, the drug industry has recommended extending such exemptions to all rare disease medications.
“We recommend extending these exemptions not only to all cancer medications but also to all rare disease medications. Such initiatives will make a significant difference in the lives of patients across India, enabling better treatment and improving overall health care outcomes,”